Education
About Us
Working with TipRanks
Follow Us
Longboard Pharmaceuticals, Inc. (LBPH)
:LBPH
RESEARCH TOOLSreports
LBPH Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Longboard Pharmaceuticals News
PremiumCompany Announcements
Longboard Pharmaceuticals Completes Acquisition and Delisting
PremiumCompany Announcements
Longboard Pharmaceuticals Advances Neurological Treatments
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
0.12% Mutual Funds
― Other Institutional Investors
99.88% Public Companies and
Individual Investors
LBPH FAQ
What was Longboard Pharmaceuticals, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Longboard Pharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is Longboard Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Longboard Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is Longboard Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Longboard Pharmaceuticals, Inc.’s price is currently Undervalued.
Does Longboard Pharmaceuticals, Inc. pay dividends?
Longboard Pharmaceuticals, Inc. does not currently pay dividends.
What is Longboard Pharmaceuticals, Inc.’s EPS estimate?
Longboard Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Longboard Pharmaceuticals, Inc. have?
Currently, no data Available
What happened to Longboard Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Longboard Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in LBPH
Company Description
Longboard Pharmaceuticals, Inc.
Longboard Pharmaceuticals (LBPH) is a clinical-stage biopharmaceutical company focused on developing novel therapies for neurological diseases. The company is dedicated to creating a pipeline of differentiated drug candidates that address unmet medical needs in various neurological conditions, with a primary focus on epilepsy and other central nervous system disorders.
Curis
―
Bioxcel Therapeutics
―
Kiniksa Pharmaceuticals
―
Aquestive Therapeutics
―
Arcutis Biotherapeutics
―
Pliant Therapeutics
―